Frontlight ResearchEarly access
Trial site
Daejeon
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration2 trials
- Asthma1 trial
- Familial hypercholesterolaemia1 trial
- Huntington's disease1 trial
- IgA nephropathy1 trial
- Lung cancer1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Huntington's disease1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026